Why Is Sarepta Therapeutics Stock Trading Lower On Tuesday? - Sarepta Therapeutics (NASDAQ:SRPT)

RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recent stock surge.

Related Keywords

,Pfizer Inc ,Sarepta Therapeutics ,